Cargando…
Well-Designed Bone-Seeking Radiolabeled Compounds for Diagnosis and Therapy of Bone Metastases
Bone-seeking radiopharmaceuticals are frequently used as diagnostic agents in nuclear medicine, because they can detect bone disorders before anatomical changes occur. Furthermore, their effectiveness in the palliation of metastatic bone cancer pain has been demonstrated in the clinical setting. Wit...
Autores principales: | Ogawa, Kazuma, Ishizaki, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446473/ https://www.ncbi.nlm.nih.gov/pubmed/26075256 http://dx.doi.org/10.1155/2015/676053 |
Ejemplares similares
-
Novel Radiolabeled Bisphosphonates for PET Diagnosis and Endoradiotherapy of Bone Metastases
por: Pfannkuchen, Nina, et al.
Publicado: (2017) -
Development of Radiolabeled Compounds for Molecular Imaging and Imaging-Based Therapy
por: Ogawa, Kazuma, et al.
Publicado: (2015) -
Radiolabeled Apoptosis Imaging Agents for Early Detection of Response to Therapy
por: Ogawa, Kazuma, et al.
Publicado: (2014) -
Radiolabeled Compounds for Diagnosis and Treatment of Cancer
por: Kumar, Krishan
Publicado: (2021) -
In Vivo and In Vitro Characteristics of Radiolabeled Vesamicol Analogs as the Vesicular Acetylcholine Transporter Imaging Agents
por: Ogawa, Kazuma, et al.
Publicado: (2018)